LT - CONTINUOUS ADMINISTRATION OF EXENATIDE AND CO-ADMINSTRATION OF ACETAMINOPHEN, ETHINYLESTRADIOL OR LEVONORGESTREL
EN - CONTINUOUS ADMINISTRATION OF EXENATIDE AND CO-ADMINSTRATION OF ACETAMINOPHEN, ETHINYLESTRADIOL OR LEVONORGESTREL
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
Bibliografiniai duomenys
Tarptautinės patentų klasifikacijos indeksai (TPK)
| (51) |
INT.CL. |
A61K 38/26 |
(2006.01) |
|
|
A61K 31/37 |
(2013.01) |
|
|
A61K 31/37 |
(2006.01) |
|
|
A61K 31/401 |
(2013.01) |
|
|
A61K 31/40 |
(2006.01) |
|
|
A61K 31/565 |
(2013.01) |
|
|
A61K 31/401 |
(2006.01) |
|
|
A61K 38/26 |
(2013.01) |
|
|
A61P 3/04 |
(2018.01) |
|
|
A61K 31/565 |
(2006.01) |
|
|
A61K 31/567 |
(2006.01) |
|
|
A61P 25/04 |
(2018.01) |
|
|
A61K 31/7048 |
(2006.01) |
|
|
A61P 9/00 |
(2018.01) |
|
|
A61P 3/10 |
(2006.01) |
|
|
A61P 25/00 |
(2018.01) |
|
|
A61K 31/167 |
(2013.01) |
|
|
A61P 15/18 |
(2018.01) |
|
|
A61K 31/567 |
(2013.01) |
|
|
A61K 31/40 |
(2013.01) |
|
|
A61K 31/7048 |
(2013.01) |
|
|
A61K 38/05 |
(2013.01) |
|
|
A61P 7/02 |
(2018.01) |
|
|
A61K 31/352 |
(2013.01) |
|
|
A61P 3/10 |
(2018.01) |
Europos patentas
| (11) |
Patento numeris |
3565580 |
| (13) |
Dokumento rūšis |
T |
| (96) |
Europos patento paraiškos numeris |
18709116.0 |
|
Europos patento paraiškos padavimo data |
2018-01-03 |
| (97) |
Europos patento paraiškos paskelbimo data |
2019-11-13 |
| (45) |
Paskelbimo apie Europos patento išdavimą data |
2024-03-06
|
| (46) |
Apibrėžties vertimo paskelbimo data |
|
Tarptautinės paraiškos padavimo
| (86) |
Numeris |
PCT/US2018/012204 |
|
Data |
2018-01-03 |
Tarptautinės paraiškos paskelbimo
| (87) |
Numeris |
WO 2018/129058 |
|
Data |
2018-07-12 |
Prioriteto paraiškos
| (30) |
Numeris |
Data |
Šalis |
|
201762441833 P |
2017-01-03
|
US |
Išradėjai
| (72) |
BARON, Michelle , US
YOUNG, Andrew , US
|
Savininkas
| (73) |
i2o Therapeutics, Inc. ,
700 Main Street, Cambridge, MA 02139,
US
|
Pavadinimas
| (54) |
CONTINUOUS ADMINISTRATION OF EXENATIDE AND CO-ADMINSTRATION OF ACETAMINOPHEN, ETHINYLESTRADIOL OR LEVONORGESTREL |
| |
CONTINUOUS ADMINISTRATION OF EXENATIDE AND CO-ADMINSTRATION OF ACETAMINOPHEN, ETHINYLESTRADIOL OR LEVONORGESTREL |
